SCOPUS 정보 검색 플랫폼

Volumn 62, Issue 3, 2002, Pages 209-215

A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer

(4) Rosati, Gerardo a,c Rossi, Antonio a Reggiardo, Giorgio b Manzione, Luigi a

a SAN CARLO HOSPITAL (Italy)

b Medi Service (Italy)

c NONE (Italy)

Author keywords

5 Fluorouracil; Alternating regimen; Colorectal cancer; Irinotecan; Leucovorin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; MALE; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; OUTPATIENT; PERFORMANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; VOMITING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CAMPTOTHECIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036285623 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000059567 Document Type: Article

Times cited : (4)

References (25)

1
- 0034712536
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
- (2000) Lancet , vol.355 , pp. 1041-1047
- Douillard, J.Y.¹ Cunningham, D.² Roth, A.D.³ Navarro, M.⁴ James, R.D.⁵ Karasek, P.⁶ Jandik, P.⁷ Iveson, T.⁸ Carmichael, J.⁹ Alakl, M.¹⁰ Gruia, G.¹¹ Awad, L.¹² Rouigier, P.¹³

2
- 0034727063
- Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
- (2000) N Engl J Med , vol.343 , pp. 905-914
- Saltz, L.B.¹ Cox, J.V.² Blanke, C.³ Rosen, L.S.⁴ Fehrenbacher, L.⁵ Moore, M.J.⁶ Maroun, J.A.⁷ Ackland, S.P.⁸ Locker, P.K.⁹ Pirotta, N.¹⁰ Elfring, G.L.¹¹ Miller, L.L.¹²

3
- 0033798125
- Colucci G on behalf of the Southern Italy Oncology Group (GOIM): 5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
- (2000) Ann Oncol , vol.11 , pp. 1045-1051
- Maiello, E.¹ Gebbia, V.² Giuliani, F.³ Paoletti, G.⁴ Gebbia, N.⁵ Cigolari, S.⁶ Fortunato, S.⁷ Pedicini, T.⁸ Borsellino, N.⁹ Lopez, M.¹⁰

4
- 0033874892
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
- (2000) J Clin Oncol , vol.18 , pp. 2938-2947
- De Gramont, A.¹ Figer, A.² Seymour, M.³ Homerin, M.⁴ Hmissi, A.⁵ Cassidy, J.⁶ Boni, C.⁷ Cortes-Funes, H.⁸ Cervantes, A.⁹ Freyer, G.¹⁰ Papamichael, D.¹¹ Le Bail, N.¹² Louvet, C.¹³ Hendler, D.¹⁴ De Broud, F.¹⁵ Wilson, C.¹⁶ Morvan, F.¹⁷ Bonetti, A.¹⁸

5
- 7844220589
- A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
- (1998) Ann Oncol , vol.9 , pp. 1199-1204
- Van Cutsem, E.¹ Pozzo, C.² Starkhammar, H.³ Dirix, L.⁴ Terzoli, E.⁵ Cognetti, F.⁶ Humblet, Y.⁷ Garufi, C.⁸ Filez, L.⁹ Gruia, G.¹⁰ Cote, C.¹¹ Barone, C.¹²

6
- 0000919664
- A phase II multicenter trial of alternating cycles of irinotecan (CPT-11) and 5-FU/LV in patients with previously untreated metastatic colorectal cancer
- (1997) Proc Am Soc Clin Oncol , vol.16 , pp. 266
- Rothenberg, M.L.¹ Pazdur, R.² Rowinski, E.K.³ Cohn, A.L.⁴ Alberts, D.S.⁵ Petit, R.G.⁶ Miller, L.L.⁷ Elfring, G.L.⁸ Murphy, T.C.⁹ Mayer, R.J.¹⁰

7
- 0031588364
- Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo
- (1997) Int J Cancer , vol.73 , pp. 729-734
- Guichard, S.¹ Cussac, D.² Hennebelle, I.³ Bugat, R.⁴ Canal, P.⁵

8
- 0028854897
- Phase I and pharmacokinetic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients
- (1995) J Clin Oncol , vol.13 , pp. 210-221
- Abigerges, D.¹ Chabot, G.G.² Armand, J.P.³

9
- 0032005592
- Irinotecan and 5-fluorouracil in colorectal cancer: Time for a pause?
- (1998) Eur J Cancer , vol.34 , pp. 286-289
- Bulusu, V.R.¹

10
- 0344109583
- Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
- (1998) J Clin Oncol , vol.16 , pp. 301-308

11
- 0025941816
- A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphon-acetyl-L-aspartic acid in patients with advanced malignancies
- (1991) Cancer , vol.68 , pp. 1242-1246
- Ardalan, B.¹ Sridhar, K.S.² Benedetto, P.³

12
- 0002760398
- Modulation of 5-fluorouracil with folinic acid: High or low dose
- Bleiberg H, Rougier P, Wilke HJ (eds). London, Dunitz
- (1998) Management of Colorectal Cancer , pp. 239-248
- Labianca, R.¹ Pessi, M.A.² Pancera, G.³ Luporini, G.⁴

13
- 9444283120
- Out-patient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial
- (1996) Ann Oncol , vol.7 , pp. 581-585
- Aranda, E.¹ Cervantes, A.² Carrato, A.³ Fernandez-Martos, C.⁴ Anton-Torres, A.⁵ Massuti, T.⁶ Barneto, I.⁷ Garcia-Conde, J.⁸ Baron, J.M.⁹ Diaz-Rubio, E.¹⁰

14
- 0345403552
- Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomized trial in patients with advanced colorectal cancer
- (1998) J Clin Oncol , vol.16 , pp. 418-426
- Köhne, C.H.¹ Schöffski, P.² Wilke, H.³ Käufer, C.⁴ Andreesen, R.⁵ Ohl, U.⁶ Klaasen, U.⁷ Westerhausen, M.⁸ Hiddemann, W.⁹ Schott, G.¹⁰ Harstick, A.¹¹ Bade, J.¹² Horster, A.¹³ Schubert, U.¹⁴ Hecker, H.¹⁵ Dörken, B.¹⁶ Schmoll, H.J.¹⁷

15
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, N.³

16
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- (1989) Controlled Clin Trials , vol.10 , pp. 1-10
- Simon, R.¹

17
- 33845382806
- Non-parametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-458
- Kaplan, E.L.¹ Meier, P.²

18
- 0032585197
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1407-1412
- Rougier, P.¹ Van Cutsem, E.² Bajetta, E.³ Niederle, N.⁴ Possinger, K.⁵ Labianca, R.⁶ Navarro, M.⁷ Morant, R.⁸ Bleiberg, H.⁹ Wils, J.¹⁰ Awad, L.¹¹ Herait, P.¹² Jacques, C.¹³

19
- 0032585232
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1413-1418
- Cunningham, D.¹ Pyrhonen, S.² James, R.D.³ Punt, C.J.A.⁴ Hickish, T.F.⁵ Heikkila, R.⁶ Johannesen, T.B.⁷ Starkhammar, H.⁸ Thopam, C.A.⁹ Awad, L.¹⁰ Jacques, C.¹¹ Herait, P.¹²

20
- 34547999425
- Irinotecan (CPT-11) alternated with Mayo Clinic regimen as treatment of first-line metastatic colorectal cancer (Crc)
- (2000) Proc Am Soc Clin Oncol , vol.19
- Salvador, J.¹ Moreno-Nogueira, J.A.² Reina, J.³ Aparicio, J.⁴ Puerto-Pica, J.⁵ Rueda, A.⁶ Lorenzo, A.⁷ Gonzalez de la Puente, C.⁸ Borrega, P.⁹ Bernabe, R.¹⁰

21
- 0009478882
- CPT-11 alternated with leucovorin +5fluorouracil (LV5FU2 regimen) in advanced colorectal cancer (ACC): A multicentric randomized phase II trial
- (2001) Proc Am Soc Clin Oncol , vol.20
- Labianca, R.¹ Martoni, A.² Galligioni, E.³ Siena, S.⁴ Barni, S.⁵ Crinò, L.⁶ Aglietta, M.⁷ Robustelli della Cuna, G.⁸ Epifani, C.⁹ Riccardi, A.¹⁰ Beretta, G.D.¹¹ Boni, L.¹² Comis, S.¹³

22
- 0009479028
- CPT-11 combined or alternating with 5 fluorouracil/folinic acid (5 FU/FA) in advanced colorectal cancer (CRC)
- (2001) Proc Am Soc Clin Oncol , vol.20
- Ben Ayed, F.¹ Khalfallah, S.² Tujakowski, J.³ Piko, B.⁴ Padrik, P.⁵ El Serafi, M.⁶ Pshevloutsky, E.⁷ Purkalne, G.⁸ Abi Gerges, D.⁹ Bapsy, P.¹⁰ Oulid-Aissa, D.¹¹ Boussard, B.¹² Bouzid, K.¹³

23
- 0023595233
- Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer
- (1987) Semin Oncol , vol.14 , Issue.SUPPL. 4 , pp. 3-11
- Hryniuk, W.M.¹ Figueredo, A.² Goodyear, M.³

24
- 0031015454
- Fluorouracil in colorectal cancer - A tale of two drugs: Implications for biochemical modulation
- (1997) J Clin Oncol , vol.15 , pp. 368-381
- Sobrero, A.F.¹ Aschele, C.² Bertino, J.R.³

25
- 0002017822
- High-dose 24- or 48-hour infusion of 5-fluorouracil plus/minus folinic acid in the treatment of metastatic colorectal cancer
- Beiberg H, Rougier P, Wilke HJ (eds). London, Dunitz
- (1998) Management of Colorectal Cancer , pp. 259-267
- Cervantes, A.¹ Dìaz-Rubio, E.² Aranda, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.